J&J's AI-Powered CARTOSOUND SONATA Aims to Streamline Cardiac Mapping
Event summary
- Johnson & Johnson launched CARTOSOUND SONATA at the 2026 Heart Rhythm Society (HRS) Annual Meeting, integrating AI with the CARTO System.
- CARTOSOUND SONATA automatically transforms intracardiac echocardiography (ICE) images into detailed cardiac maps, identifying and labeling structures.
- The module integrates with SOUNDSTAR CRYSTAL and NUVISION NAV ultrasound catheters, supporting procedures for atrial fibrillation, ventricular tachycardia, and complex concomitant procedures.
- This launch coincides with the 30th anniversary of the CARTO System, highlighting its evolution and foundational role in electrophysiology.
The big picture
J&J’s CARTOSOUND SONATA represents a strategic move to leverage AI in a mature market—electrophysiology—where procedural efficiency and accuracy are paramount. The company’s focus on integrating AI into the established CARTO platform, rather than developing a completely new system, minimizes risk but also requires demonstrating a clear advantage over existing solutions. This aligns with a broader trend in MedTech towards AI-powered diagnostics and therapeutics, which is attracting significant investment and driving consolidation within the industry.
What we're watching
- Adoption Rate
- The speed at which hospitals and electrophysiologists adopt CARTOSOUND SONATA will determine its impact on J&J’s electrophysiology revenue and market share.
- Competitive Response
- Competitors like EnSite will likely accelerate their own AI-driven imaging solutions, potentially eroding J&J’s competitive advantage in cardiac mapping.
- Clinical Validation
- Continued clinical data demonstrating improved patient outcomes and workflow efficiency will be crucial for securing reimbursement and widespread adoption of CARTOSOUND SONATA.
Related topics